NewsBenzinga에드워즈 라이프사이언시스, 삼첨판막 수리용 파스칼 시스템이 CLASP II TR 임상시험 6개월 1차 평가에서 단독 약물 치료 대비 우월성 입증 에드워즈 라이프사이언시스, 삼첨판막 수리용 파스칼 시스템이 CLASP II TR 임상시험 6개월 1차 평가에서 단독 약물 치료 대비 우월성 입증 Benzinga 2026.11.02 18:30 (GMT+0) Open on Benzinga Other news Huobi HTX to Open Spot Trading for SOXS, KORU and SNXX on November 17 Duan Yongping Trims Nvidia and Apple in Q3, Exits Alibaba and CRCL, Opens New SpaceX Stake Ethereum Glamsterdam upgrade testing finds bug: some internal payments skipped while transaction succeeds US Says Justice Leads Megaspeed AI-Chip Investigation Soluna Holdings, Inc. (SLNH) Q3 2026 Earnings Call Transcript ‘The Odds Are Almost Zero’: Scott Galloway Doesn’t See Jensen Huang Returning to Nvidia
Ethereum Glamsterdam upgrade testing finds bug: some internal payments skipped while transaction succeeds